Treatment of type 2 diabetes with incretin-based therapies (Q46344899)

From Wikidata

Jump to navigation Jump to search

scientific article published on 24 September 2008

edit

Language	Label	Description	Also known as
English	Treatment of type 2 diabetes with incretin-based therapies	scientific article published on 24 September 2008

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18819704

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/18819704

title

Treatment of type 2 diabetes with incretin-based therapies (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18819704

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/18819704

main subject

type 2 diabetes

0 references

author

Sten Madsbad

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18819704

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/18819704

language of work or name

English

0 references

publication date

24 September 2008

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18819704

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/18819704

published in

The Lancet

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18819704

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/18819704

volume

373

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18819704

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/18819704

issue

9662

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18819704

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/18819704

page(s)

438-439

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18819704

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/18819704

cites work

The Physiology of Glucagon-like Peptide 1

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961247-7

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Glucagon-like peptide-1, glucose homeostasis and diabetes

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961247-7

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961247-7

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Glucagon-like peptide receptor agonists and dipeptidyl peptidase-4 inhibitors in the treatment of diabetes: a review of clinical trials

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961247-7

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961247-7

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961247-7

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitus

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961247-7

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961247-7

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

DOI

10.1016/S0140-6736(08)61247-7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18819704

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/18819704

PubMed publication ID

18819704

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18819704

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/18819704

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46344899&oldid=2126993581"